Critics Blast FDA Plan For RADARS Drug Misuse Surveillance Program

The Research, Abuse, Diversion, and Addiction-Related Surveillance system was an in-house system at Purdue Pharma and later sold to the Denver Health and Hospital Authority. Advocacy groups are pushing back against the FDA's use of RADARS over its ties to the pharma industry.

Related Keywords

Pennsylvania ,United States ,Kentucky ,Massachusetts ,Denver ,Colorado ,Mike Cusnir ,Andy Beshear ,Department Of Health ,Hospital Authority ,Drug Misuse Surveillance Program ,Denver Health ,Purdue Pharma ,Drug Administration ,Critics Blast ,Misuse Surveillance ,Addiction Related Surveillance ,Daniel Costa ,Rewarding Recovery ,New England Journal ,Chief Oncologist ,Mount Sinai Hospital ,Dry January ,Damp January ,